GET THE APP

Coronavirus | Covid-19 | Peer Reviewed Journals Articles | Role of Remdesivir, Lopinavir, Chloroquine, Hydroxychloroquine in the treatment of Covid 19 pandemic
Journal of Applied Pharmacy

Journal of Applied Pharmacy
Open Access

ISSN: 1920-4159

+44 7480022449

Role of Remdesivir, Lopinavir, Chloroquine, Hydroxychloroquine in the treatment of Covid 19 pandemic

Role of Remdesivir, Lopinavir, Chloroquine, Hydroxychloroquine In The Treatment of Covid 19 Pandemic

Journal of Applied Pharmacy is pleased to announce Special issue on “Role of Remdesivir, Lopinavir, Chloroquine, Hydroxychloroquine In The Treatment of Covid 19 Pandemic”. COVID-19 is a respiratory illness which has infected more than 200 countries and has killed more than two hundred thousand people globally. So, in the desperate search to find effective treatments for coronavirus disease 2019 (COVID-19), 2 generic drugs, used largely by rheumatologists and dermatologists to treat immune-mediated diseases, have entered the spotlight. The antimalarials hydroxychloroquine (HCQ) and chloroquine (CQ) have demonstrated antiviral activity against severe acute respiratory syndrome–coronavirus 2 (SARS–CoV-2) in vitro and in small, poorly controlled or uncontrolled clinical studies.The drugs have some in vitro activity against several viruses, including coronaviruses and influenza, but previous randomized trials in patients with influenza have been negative. So, we want to provide the scientific community a platform to showcase their studies globally.  
With the same purpose our Journal “Journal of Applied Pharmacy” is announcing Special issue Call for paper on “Role of Remdesivir, Lopinavir, Chloroquine, Hydroxychloroquine In The Treatment of Covid 19 Pandemicduring COVID-19”. We welcome both solicited and unsolicited submissions that will contribute to this special issue.
Submission Process 
Special issue articles can include both original unpublished research articles and review articles related to the specific theme
Manuscripts will be accepted for publishing in the special issue only after getting approved by the peer review committee.
All the articles in special issues should strictly adhere to journal style and formatting.
Each special issue can be created with 5-7 articles.
All accepted manuscripts can be submitted online via https://www.longdom.org/submissions/applied-pharmacy.html or through an email id to  [email protected]
Submission should be accompanied by a cover letter with reference to the concerned special issue theme.
Please visit Instruction for authors page to know more about article formatting and guidelines: https://www.longdom.org/applied-pharmacy/instructionsforauthors.html

Top